• EPISODE 24- When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act

    Joe Allen, Executive Director of The Bayh-Dole Coalition, was at the forefront of the Bayh-Dole Act back in December 1980

  • EPISODE 23- Beyond Medicine: Solving Disparities in Cancer Care

    How can we create better outcomes for cancer patients?

  • EPISODE 22- Balancing Access & Affordability in the Future of Healthcare

    Can we create a future healthcare system that is accessible and affordable for all patients?

  • EPISODE 21- Making Patients the Center of U.S. Healthcare Reform

    In this episode, MacKay Jimeson, Executive Director of The Patient Access & Affordability Project at Patients Rising, joins the show to explain how the system was never designed for patients, the benefits of a patient-centric system, and what the future holds for the industry.

  • EPISODE 20- Innovations in Women’s Health & Entrepreneurship

    Even though 80% of the household decisions around health are made by women, only 4% of research and funding goes towards women’s health research. In today’s episode, Natalie Buford-Young, Chief Executive Officer at Springboard Enterprises, joins us to discuss Springboard’s mission and how they are exploring a designated network to create pathways for emerging female innovators. We also get to hear about Natalie's experience testifying on the Hill to advocate for reducing the decline of women's entrepreneurship. Join us as we discuss: · Innovation in digital health and life sciences; · The Women's Health Innovation Coalition; and · Increasing diversity in clinical trials.

  • EPISODE 19- The Inflation Reduction Act: A Big Issue for Small-Molecule Medicine

    Runaway inflation and economic instability is terrible for just about everybody, but are efforts to tackle this problem creating more? To answer that, Kirsten Axelsen, Senior Policy Advisor at DLA Piper, joins the show to break down all the effects The Inflation Reduction act is having upon medicine.

  • EPISODE 18- From the JP Morgan Conference: The Impact of the Inflation Reduction Act

    John was at the JP Morgan conference and is here to discuss the key takeaways of the Inflation Reduction Act: the small-molecule penalty, the value of small-molecule drugs, the importance of incentivizing post-approval research, intellectual property, and non-coverage decisions at CMS. You’ll also hear John’s take on the demand for a more pro-patient agenda.

  • EPISODE 17- The Three Pillars of Bio & Medtech Investing and Industry Impact of DEI

    This episode of Making Medicine features Christine Brennan, Managing Director, Vertex Venture HC, where we discuss how diversity, equity, and inclusion are critical for the life sciences industry.

  • EPISODE 16- Understanding Health Equity

    This episode of Making Medicine features Dr. Jerome Adams, Executive Director of Health Equity Initiatives at Purdue University and the 20th Surgeon General of the United States on the importance of health equity and accessible care.

  • EPISODE 15- Addressing The Overlooked AMR Problem

    This episode of Making Medicine features Dr. Henry Skinner, CEO of the AMR Action Fund, who discusses the urgency of finding solutions for AMR and how the fund aims to help.

  • EPISODE 14- Pro-Patient Reforms: The Outlook for 2022

    In this episode, Making Medicine Host John Stanford is featured as a guest, as he discusses the policy outlook for 2022 with Ashlyn Roberts, our Coalition Manager.

  • EPISODE 13- How Better Data Fosters Health Equity

    In this episode, we interview Kirsten Axelsen on the importance of better representation in clinical trials.